Astec LifeSciences Limited IPO (Astec IPO) Detail

Oct 29, 2009 - Nov 4, 2009

Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Hexaconazole, Tebuconazole, Metalaxyl and Propiconazole are some of their key products in agrochemical segment which are generally used in crop protection and Dicap is one of the key Pharmaceutical intermediate which is used in manufacture of antifungal agents.

Astec has multipurpose production facilities at 2 locations.

1. Dombivli - 1 plant (50km from Mumbai)
2. Mahad - 2 plants ( 180 kms from Mumbai)

Astec started it's first manufacturing unit in August 1994 in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap. In the year of 2002, Astec entered into an agreement with Behram Chemicals Private Limited for using and operating their manufacturing facilities located at Mahad Industrial Area, Maharashtra. During 2003-04 company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT.

Astec has been granted ISO 9001:2000 Certificate of Assessment by International Standards Certification Pvt limited, Australia for “Design, Development, Manufacture and Supply of Organic Chemical and Intermediates for Pharmaceutical and Agrochemical Industry”.

Company Promoters:

Astec LifeSciences is promoted by 2 entrepreneurs:

1. Mr. Ashok Hiremath - aged 54 years, is a Masters of Arts from University of Oxford and Post Graduate Diploma holder in Chemical Engineering from University College, University of London.

2. Dr. P.L. Tiwari - aged 64 years, is a MBBS and MD (Medicine) from Banaras Hindu University. He is a Member of the Royal College of Physicians of the United Kingdom (MRCP) and Fellow of Royal College of Physicians, Edinburgh (FRCP). He is a practicing cardiologist in Mumbai. He was awarded UP Ratna award in January, 1996 by the Chief Minister of Maharashtra. He was also awarded L U Kirpalani Memorial Award for Life Time Achievement- 2005 by A’ward Medical Association.

Objects of the Issue:

The objects of the Issue are to achieve the benefits of listing on the Stock Exchanges & to raise capital:

1. Expansion of our existing manufacturing facilities at Mahad, Maharashtra;
2. Expansion of our existing Research and Development facility at Dombivli, Maharashtra;
3. Meeting Registration expenses;
4. Meeting long-term working capital requirements;
5. General Corporate Purposes;
6. Issue Expenses.

Astec IPO Details

IPO DateOct 29, 2009 - Nov 4, 2009
Issue TypeBook Built Issue IPO
Issue Size7,500,000 Eq Shares of ₹10
(aggregating up to ₹61.50 Cr)
Face Value₹10 Per Equity Share
IPO Price₹77 to ₹82 Per Equity Share
Market Lot75 Shares
Min Order Quantity75 Shares
Listing AtBSE, NSE

Astec IPO Lot Size and Price (Retail)

ApplicationLotsSharesAmount (Cut-off)
Minimum175₹6,150
Maximum322400₹196,800

Astec LifeSciences Limited IPO Grading / Rating

CARE has assigned an IPO Grade 2 to Astec LifeSciences Limited IPO. This means as per CARE, company has below average fundamentals. CARE assigns IPO gradings on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Link to download CARE rating document.

Astec IPO Subscription Status (Bidding Detail)

Astec IPO how much subscribed?

No. of Times Issue Subscribed (BSE + NSE)

As on Date & Time

QIB

NII

RII

Employee

Total

Shares Offered

3,700,000

1,110,000

2,590,000

100,000

7,500,000

Nov 4, 2009 17:00

0.61x

3.00x

2.36x

0.50x

1.56x

Astec IPO Prospectus

Astec IPO Rating

107
3.3
Rating:Rated 3.3 stars

Vote Here ...

Astec IPO Listing Date

Listing DateWednesday, November 25, 2009
BSE Script Code533138
NSE SymbolASTEC
Listing InB
ISININE563J01010
IPO Price₹82 Per Equity Share
Face Value₹10 Per Equity Share

Listing Day Trading Information

.
IPO Price
Open
Low
High
Last Trade
Volume
BSE
₹82.00
₹85.55
₹80.00
₹90.70
₹83.90
12,260,573
NSE
₹82.00
₹83.00
₹83.00
₹90.70
₹84.00
13,242,907

Astec IPO Reviews / Ratings

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Astec LifeSciences Limited
5-5A, 4th floor,
Kamanwala Chambers, Sir P. M. Road,
Fort, Mumbai - 400001

Phone: +91-22-2261 8212-13
Email: ipo@astecls.com
Website: http://www.astecls.com

Astec IPO Registrar

Bigshare Services Pvt Ltd
   1st Floor, Bharat Tin Works Building,
   Opp. Vasant Oasis,Makwana Road,
   Marol, Andheri(E), Mumbai - 400 059

Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com

Astec IPO FAQs

  1. 1. What is Astec IPO?

    Astec IPO is a main-board IPO of 7,500,000 equity shares of the face value of ₹10 aggregating up to ₹61.50 Crores.

    The issue price of the IPO is ₹77 to ₹82 Per Equity Share. The minimum order quantity is 75 Shares per application and the offer type is Book Built Issue.

    The IPO opens on Oct 29, 2009 and closes on Nov 4, 2009.

    Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

  2. 2. When Astec IPO will open?

    The Astec IPO opens on Oct 29, 2009 and closes on Nov 4, 2009.

  3. 3. How to apply for Astec IPO?

    Astec IPO application can be done through banks using ASBA online or through stock brokers trading account using UPI. All popular banks i.e. HDFC, ICICI, and SBI offer online IPO applications. An investor can also apply directly through their broker (i.e. Zerodha, Sharekhan) using UPI as a payment method.

  4. 4. When Astec IPO allotment?

    The finalization of Basis of Allotment for Astec IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Astec IPO allotment status.

  5. 5. When is Astec IPO listing date?

    The Astec IPO listing date is on Wednesday, November 25, 2009, at BSE, NSE.
  6. 6. What is the lot size of Astec IPO?

    Astec IPO lot size is 75 Shares and the minimum order quantity is 75 Shares.

Guaranteed Save 60% to 90% Brokerage

You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.

We can help you choosing the right broker. Contact us today...

Astec IPO Review / Comments

Rama
104. Rama  Dec 19, 2009 13:24
Astec 1 Yr price target: Rs. 50-55
Ravi, Bangalore
103. Ravi, Bangalore  Dec 2, 2009 14:15
Astec Lifescience 90- Target 88-91 zone, 94-95 zone. Stop-loss 82.9. Buy in 91-88 range.

Fundamentally over-valued. Hence, stop-loss is important.
NAGESH K S
102. NAGESH K S  Nov 26, 2009 13:05
All Life Sciens stocks trading at high p/e this will all outperforma the market in the near future.
Ravi, Bangalore
101. Ravi, Bangalore  Nov 25, 2009 13:27
As it is small issue size IPO, it is defying gravitation power. At least in near-term, fundamental won't catch up.

It is moving on technical factors (demand & supply). Keep stop-loss & gamble. Playing without stop-loss is like drving without brake.
Rama
100. Rama  Nov 25, 2009 12:59
My final advice: Sell astec... This stock is not for investment...
Ravi, Bangalore
99. Ravi, Bangalore  Nov 25, 2009 12:01
Modify intra-day stop-loss to 86.5 as it has tested 86.8 thrice since morning.
Ravi, Bangalore
98. Ravi, Bangalore  Nov 25, 2009 11:57
Astec 87.2- Above 87.2, break-out. Target 88, 89, 89.5 Stop-loss 86.9 (Intra-day)
Astec
97. Astec  Nov 25, 2009 08:51
Astec will list @ 73
Rama
96. Rama  Nov 25, 2009 08:46
Sell........Sell..........Sell......
There is no value for shares API manufacturers. Uncertain business.
If you can take some risk and want to ride some operator action, then you can hold for 2-3 days(See whether this follows thinksoft trend).
Discl: I dont have astec shares.
prakash ipo & kings
95. prakash ipo & kings  Nov 24, 2009 19:53

It may list Rs.88 to Rs.90.

then further its trend will be up side.

H A P P Y - L I S T I N G .
rama
94. rama  Nov 24, 2009 14:41
Astec may give Rs. 1 listing gain. Adviced to sell above 84/. buy below 50/
Ravi, Bangalore
93. Ravi, Bangalore  Nov 24, 2009 13:15
92. Rama,

Cheap stocks becomes more cheap and expensive stocks become further expensive.

Just because you pick-up value stocks, it does not guarantee safety. Stock market, by its nature itself is risky whether you buy value stocks or growth stocks. At investors cash comfortable level, stop-loss is required.
Rama
92. Rama  Nov 24, 2009 08:43
To 89. Ravi,
You are correct. But it is not my job to suggest when DLF etc stocks makes new highs. Because I dont invest based on their ability ot make new highs. I invests if a stock is available at reasonable PE. Some stocks may trade at high PE(since stocks valued with p/book, PEG, EV/mCap etc). But when more more stocks list from the same sector, people go for PE comparison... otr atleast that is what I do.... I may miss some good growth stocks, but in bad times my loss also limited!!!! from my investing strategy I will remain breakeven till sensex level of 11800. So that is fine with me and is suitable for my risk profile
BHIMANI
91. BHIMANI  Nov 23, 2009 18:19
INE563J01010
PRICE: 82/- Rs.
BSE ~ 533138
NSE ~ ASTEC
LISTING CEREMONY ON 25th NOVEMBER, WEDNESDAY.
ALI  BHOY  SAKAR  BAZAR  WALA
90. ALI BHOY SAKAR BAZAR WALA  Nov 23, 2009 16:36


LISTING DATE IS OUT

IT IS ON

25 th NOV. Wednesday
.
Ravi, Bangalore
89. Ravi, Bangalore  Nov 23, 2009 16:27
88. Rama

Investment in stock market by nature itself is risky. However, what deterrs is huge volatility. Scam tainted / Operators stock lose 90% or more.

If any fundamental value is there & SEBI is alert (Exchanges are equipped with functional stock watch systems), it can prevent such volatility.

SEBI can restict block money flowing to market (SEBI / RBI have experitse & tools to verify fund-flow).

'A' Group companies falling more than 75% is a failure of regulator.

Investors also should be vary. Investors should not apply to high PE multiple IPOs. They should not chase stocks at high PE multiple in secondary market. To manage market risk, stop-loss is necesssary.

Eg: Had any investor not put stop-loss, it is tough to imagine when Satyam would hit new high! Even can you tell when frontline stocks like DLF, Unitech would cross their respective new highs? Even long-term investors lose money.
rupesh bharatwala
88. rupesh bharatwala  Nov 23, 2009 15:17
can any one tell me about listing date of astec life science ltd
Rama
87. Rama  Nov 23, 2009 15:15
To Ravi, 87:
Eventhough your points looks reasonable, it is difficult to practise. SEBI cannot watch each script everyday. that is why A, B, Z, T etc stock catogories aree there, also associated circuit filters. Investors has to take due care before trading. Because stock market is part of free capital market. So risk will always be very high. No risk..means one have to go for bank fixed deposits.
After reading your views it appears that after IPO, share price should not go below issue price or shouldnot go above issue price!!!!
rama
86. rama  Nov 21, 2009 08:53
Chithorgarh staff should remove mesages like No 86, which is simply waste of time. Nobody snatched money from us. It is WE who have taken risk and applied for IPO's like NHPC. Nobody else can be blame for that....
To Chithorgarh staff.....
Please REMOVE JUNK MESSAGES.
K V Subba Rao
85. K V Subba Rao  Nov 18, 2009 11:20
allotment out 640 shares to full application prem is rs.4.5 enjoy listing listing date is also out 27 nov






Search Chittorgarh.com:

Chittorgarh.com Mobile Apps:

Download Android App Downlaod iOS App